Skip to content

Home
Team
Portfolio
News
- TCG News
- Portfolio News
Careers
Contact

Menu

Home
Team
Portfolio
News
- TCG News
- Portfolio News
Careers
Contact

Month: August 2017

FLX Flexing Against Suppression

Portfolio News / By admin

August 10, 2017

Search for:

Recent Posts

Atavistik Bio Announces $60 Million Series A Financing to Advance Genetically-Validated Targets in Metabolic Diseases and Cancer
NGM Bio Discloses Fourth Oncology Development Candidate, NGM831, an ILT3 Antagonist Antibody, Coinciding with Publication in Cancer Immunology Research
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
RAPT Therapeutics Reports Second Quarter 2021 Financial Results
Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress

Recent Comments

Archives

Categories

Portfolio News
TCG News

The Column Group

Copyright © 2021. The Column Group | Privacy Policy | Terms of Use
Website developed by CP Communications

Scroll to Top